Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2008
11/27/2008WO2008143552A1 Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence
11/27/2008WO2008143551A1 Active ingredient of a medicinal agent, a medicinal agent, a pharmaceutical composition and method for treating dementia syndrome patients
11/27/2008WO2008143490A1 Pharmaceutical composition combining an anticonvulsant agent and an antiviral agent
11/27/2008WO2008143489A1 Pharmaceutical composition combining a non-steroidal anti-inflammatory agent and an anticonvulsant agent
11/27/2008WO2008143361A1 A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
11/27/2008WO2008143280A1 Sedative agent
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008143262A1 Heterocyclic compound and use thereof
11/27/2008WO2008143241A1 Method for producing pharmaceutical tablet
11/27/2008WO2008143240A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008WO2008143239A1 Crystalline micropowder particles
11/27/2008WO2008142693A2 Regulation of myelination by nectin-like (necl) molecules
11/27/2008WO2008142463A2 Carbamoyl-cyclohexanes for treating acute mania
11/27/2008WO2008142462A1 (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia
11/27/2008WO2008142461A1 Metabolites of (thio)carbamoyl-cyclohexane derivatives
11/27/2008WO2008142319A2 Peptide analogues of melanocortin receptors
11/27/2008WO2008142231A2 Novel composition based on cholest-4-ene-3-one oxime
11/27/2008WO2008142194A1 Method for the in vitro diagnosis/prognosis of huntington's chorea
11/27/2008WO2008142140A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/27/2008WO2008142134A1 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions
11/27/2008WO2008141843A1 Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
11/27/2008WO2008112651A3 Aminopyrimidines useful as inhibitors of protein kinases
11/27/2008WO2008101693A3 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds
11/27/2008WO2008101692A3 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline
11/27/2008WO2008101247A3 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
11/27/2008WO2008096271A3 Neuroprotection in demyelinating diseases
11/27/2008WO2008092072A3 Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof
11/27/2008WO2008087123A3 Use of 5-ht6 antagonists to prevent relapse into addiction
11/27/2008WO2008071438A3 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor
11/27/2008WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives
11/27/2008WO2008058210B1 Local administration of gallium compositions to treat pain
11/27/2008WO2008046087A3 Spiro compounds and their uses as therapeutic agents
11/27/2008WO2008046072A3 Chemical inducers of neurogenesis
11/27/2008WO2008031771A3 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression
11/27/2008WO2008024438A3 2-phenoxy pyrimidinone analogues
11/27/2008WO2008021932A3 Milnacipran for the treatment of cognitive dysfunction associated with fibromyalgia
11/27/2008WO2008014219A3 Thiozolidinedione derivatives as p13 kinase inhibitors
11/27/2008WO2007138339A3 Treatment of pain by use of a single chain polypeptide fusion protein
11/27/2008WO2007098086A3 Hydroxypiperidine derivatives and uses thereof
11/27/2008US20080293822 Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
11/27/2008US20080293812 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
11/27/2008US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents
11/27/2008US20080293794 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
11/27/2008US20080293792 (R)-2-(9-(1H-imidazol-1-yl)nonyl)-2,5,7,8-tetramethylchroman-6-ol, capable of inhibiting tocopherol-omega-hydroxylase, responsible for the metabolism of tocopherol and tocotrienol compounds of vitamin E, and thus increase the amount and prolong the bioavailability of these compounds in plasma and tissue
11/27/2008US20080293790 Substituted aryl oximes
11/27/2008US20080293786 Novel 2-imino-1,3-thiazoline-based compounds and t-type calcium channel inhibitors containing the same
11/27/2008US20080293785 Substituted benzothiazole kinase inhibitors
11/27/2008US20080293782 1,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors
11/27/2008US20080293781 Salicylic Acid Derivatives
11/27/2008US20080293778 Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
11/27/2008US20080293771 Azacyclylbenzamide derivatives as histamine-3 antagonists
11/27/2008US20080293770 Psychological disorders; cognition activators
11/27/2008US20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity
11/27/2008US20080293765 Alkylsulphonamide Quinolines
11/27/2008US20080293753 Novel Compounds
11/27/2008US20080293751 Tetralin and indane derivatives and uses thereof
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293740 Method of treating acid-sensing ion channel mediated pain, cough suppression, and central nervous system disorders
11/27/2008US20080293739 Compounds for modulating t-cells
11/27/2008US20080293737 Ion channel modulators and methods of use
11/27/2008US20080293736 Compositions, Synthesis, and Methods of Using Quinolinone Based Atypical Antipsychotic Agents
11/27/2008US20080293731 Organic Compounds
11/27/2008US20080293728 Complexes Comprising alpha2-Adrenergic Receptor Agonists and Compositions
11/27/2008US20080293726 Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
11/27/2008US20080293722 Ion Channel Modulators
11/27/2008US20080293721 Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases
11/27/2008US20080293718 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia
11/27/2008US20080293709 Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related Pathologies
11/27/2008US20080293695 Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
11/27/2008US20080293692 Amidating a succinamic acid with a 3-aminolactam to prepare compounds, such as N1-[1,3-dihydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(allyl)-butanediamide
11/27/2008US20080293690 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/27/2008US20080293688 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
11/27/2008US20080293686 Semi-solid systems containing azetidine derivatives
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008US20080293680 Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293642 C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same
11/27/2008US20080293639 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080292733 Antioxidant and Fe2+ Chelating Properties of Herbal Extracts
11/27/2008US20080292724 Composition for improving membrane composition and functioning cells
11/27/2008US20080292712 Methods and compositions for enhanced delivery of bioactive molecules
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292700 Controlled release formulations using intelligent polymers
11/27/2008US20080292694 Opioid agonist/antagonist combinations
11/27/2008US20080292681 Use of Dha, Epa or Dha-Derived Epa for Treating a Pathology Associated with Cellular Oxidative Damage
11/27/2008US20080292642 Crystalline anti-human IL-12 antibodies
11/27/2008US20080292639 Humanized Anti-Amyloid Antibody
11/27/2008US20080292625 Prevention and treatment of cerebral amyloid angiopathy
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292607 Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
11/27/2008US20080292603 Treatment and prevention of neurodegenerative diseases using gene therapy
11/27/2008US20080292597 Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
11/27/2008US20080292593 Gene therapy for spinal cord disorders
11/27/2008US20080292582 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE102007024802A1 Use of an active substance mixture comprising a fraction specific peptide and fraction essential and non-essential amino acids for the production of a composition to treat, prophylaxis and/or metaphylaxis of e.g. dementia disease
11/27/2008DE102007024470A1 New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis
11/27/2008DE102007024428A1 Use of naloxone for producing a medicament devoid of non-oral abuse-potential for humans, where the medicament contains a psychotropic substance, which is useful for treating attention deficit hyperactivity disorder
1 ... 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 ... 1833